AUPH Q4 2017 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$31,000+3.3% YoY

Gross Profit

-$9M-27935.5% margin

Operating Income

-$12M-39158.1% margin

Net Income

-$3M-10748.4% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

+6.9%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$955,000

Balance Sheet

Total Assets

$190M

Total Liabilities

$24M

Stockholders' Equity

$166M

Cash & Equivalents

$166M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31,000	$30,000	+3.3%
Gross Profit	-$9M	$29,000	-29962.1%
Operating Income	-$12M	-$8M	-51.3%
Net Income	-$3M	-$8M	+60.0%